Recent Investment Analysts’ Ratings Updates for Elevance Health (ELV)
Several analysts have recently updated their ratings and price targets for Elevance Health (NYSE: ELV): 4/29/2026 – Elevance Health was upgraded by Citigroup Inc. to “buyâ€. 4/29/2026 – Elevance Health was upgraded by Bank of America Corporation from “neutral†to “buyâ€. They now have a $435.00 price target on the stock, up from $405.00. 4/28/2026 […]
Generated by Pulse AI, Glideslope's proprietary engine for interpreting market sentiment and economic signals. For informational purposes only — not financial advice.